omega-n-methylarginine has been researched along with Carotid Artery Diseases in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bralley, JA; Chirinos, JA; Chirinos-Pacheco, J; Corrales-Medina, F; Cuba-Bustinza, C; David, R; Medina-Lezama, J; Muñoz-Atahualpa, E; Zea-Díaz, H | 1 |
Bennett, MR; Boyle, JJ; Weissberg, PL | 1 |
2 other study(ies) available for omega-n-methylarginine and Carotid Artery Diseases
Article | Year |
---|---|
Endogenous nitric oxide synthase inhibitors, arterial hemodynamics, and subclinical vascular disease: the PREVENCION Study.
Topics: Aged; Aged, 80 and over; Arginine; Biomarkers; Blood Flow Velocity; Blood Pressure; Carotid Artery Diseases; Female; Humans; Hypertension; Male; Middle Aged; Nitric Oxide Synthase Type III; omega-N-Methylarginine; Predictive Value of Tests; Prognosis; Pulsatile Flow; Regression Analysis; Risk Factors | 2008 |
Human macrophage-induced vascular smooth muscle cell apoptosis requires NO enhancement of Fas/Fas-L interactions.
Topics: Apoptosis; Autocrine Communication; Carotid Artery Diseases; Cells, Cultured; Enzyme Inhibitors; Fas Ligand Protein; fas Receptor; Golgi Apparatus; Humans; Ligands; Macrophages; Membrane Glycoproteins; Muscle, Smooth, Vascular; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Donors; Nitric Oxide Synthase; Nitric Oxide Synthase Type II; Nitroprusside; omega-N-Methylarginine; Polyamines; Protein Transport; Up-Regulation | 2002 |